High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overexpression of interleukin 22

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Wang, Zheng ^a   Yang, Ling ^a   Jiang, Yuhui ^a   Ling, Zhi Qiang ^b   Li, Zhigang ^a   Cheng, Yuan ^a   Huang, Heng ^a   Wang, Lingdi ^a   Pan, Yi ^a   Wang, Zhenzhen ^a   Yan, Xiaoqiang ^c   Chen, Yan ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c Generon Corporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 22; MITOGEN ACTIVATED PROTEIN KINASE; CYTOKINE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE OVEREXPRESSION; GLUCOSE METABOLISM; INSULIN RESISTANCE; LIPID DIET; LIPOSARCOMA; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSGENE; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CYTOKINES; DIET, HIGH-FAT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; INTERLEUKINS; LIPOSARCOMA; MALE; MICE; MICE, TRANSGENIC; PHOSPHORYLATION;

EID: 80052301263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023737     Document Type: Article

References (35)

1. Dumoutier L, Louahed J, Renauld JC, (2000) Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164: 1814-1819.
2. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, et al. (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275: 31335-31339.
3. Witte E, Witte K, Warszawska K, Sabat R, Wolk K, (2010) Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev 21: 365-379.
4. Zenewicz LA, Flavell RA, (2011) Recent advances in IL-22 biology. Int Immunol 23: 159-163.
5. Ma HL, Liang S, Li J, Napierata L, Brown T, et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118: 597-607.
6. Weber GF, Schlautkotter S, Kaiser-Moore S, Altmayr F, Holzmann B, et al. (2007) Inhibition of interleukin-22 attenuates bacterial load and organ failure during acute polymicrobial sepsis. Infect Immun 75: 1690-1697.
7. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118: 534-544.
8. Chang H, Hanawa H, Liu H, Yoshida T, Hayashi M, et al. (2006) Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats. J Immunol 177: 3635-3643.
9. Pan H, Hong F, Radaeva S, Gao B, (2004) Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell Mol Immunol 1: 43-49.
10. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, et al. (2010) Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52: 1291-1300.
11. Radaeva S, Sun R, Pan HN, Hong F, Gao B, (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342.
12. Park O, Wang H, Weng H, Feigenbaum L, Li H, et al. (2011) In vivo consequences of liver-specific interleukin-22 expression: Implications for human liver disease progression. Hepatology 54: 252-261.
13. Zhang W, Chen Y, Wei H, Zheng C, Sun R, et al. (2008) Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 14: 6432-6439.
14. Weber GF, Gaertner FC, Erl W, Janssen KP, Blechert B, et al. (2006) IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase. J Immunol 177: 8266-8272.
15. Yang L, Zhang Y, Wang L, Fan F, Zhu L, et al. (2010) Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J Hepatol 53: 339-347.
16. Xie X, Zhang Y, Jiang Y, Liu W, Ma H, et al. (2008) Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse. Carcinogenesis 29: 1632-1638.
17. Wu PW, Li J, Kodangattil SR, Luxenberg DP, Bennett F, et al. (2008) IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. J Mol Biol 382: 1168-1183.
18. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-899.
19. Cobb MH, (1999) MAP kinase pathways. Prog Biophys Mol Biol 71: 479-500.
20. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, et al. (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25: 2097-2116.
21. Aggarwal BB, Vijayalekshmi RV, Sung B, (2009) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15: 425-430.
22. Wellen KE, Hotamisligil GS, (2005) Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
23. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
24. Park EJ, Lee JH, Yu GY, He G, Ali SR, et al. (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140: 197-208.
25. Riggi N, Cironi L, Provero P, Suva ML, Stehle JC, et al. (2006) Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 66: 7016-7023.
26. Rodriguez R, Rubio R, Gutierrez-Aranda I, Melen GJ, Elosua C, et al. (2010) Fus-Chop Fusion Protein Expression Coupled to P53 Deficiency Induces Liposarcoma in Mouse but not Human Adipose-Derived Mesenchymal Stem/Stromal Cells. Stem Cells 29: 179-192.
27. Dei Tos AP, (2000) Liposarcoma: new entities and evolving concepts. Ann Diagn Pathol 4: 252-266.
28. Sandberg AA, (2004) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 155: 1-24.
29. Kraus MD, Guillou L, Fletcher CD, (1997) Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. Am J Surg Pathol 21: 518-527.
30. Ren K, Torres R, (2009) Role of interleukin-1beta during pain and inflammation. Brain Res Rev 60: 57-64.
31. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, et al. (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21: 331-344.
32. Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, et al. (1997) Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 71: 630-637.
33. Zeng L, O'Connor C, Zhang J, Kaplan AM, Cohen DA, (2010) IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines. Cytokine 49: 294-302.
34. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, et al. (2002) Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277: 33676-33682.
35. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, et al. (2006) IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 290: G827-838.